Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Activation and suppression of the TRAIL death-receptor pathway in chemotherapy sensitive and resistant follicular lymphoma cells.

Wagner KW, King F, Nomoto K, Knee DA, Hampton G, Nasoff M, Deveraux QL.

Cancer Biol Ther. 2003 Sep-Oct;2(5):534-40.

PMID:
14614322
2.

Resistance of follicular lymphoma cells to chemotherapy is more than just BCL-2.

Hersey P, Zhang XD.

Cancer Biol Ther. 2003 Sep-Oct;2(5):541-3. No abstract available.

PMID:
14614323
3.

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.

Oncogene. 2006 Dec 7;25(58):7618-34. Epub 2006 Sep 18. Erratum in: Oncogene. 2007 Feb 22;26(8):1256.

PMID:
16983347
6.
7.

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.

Jaganathan J, Petit JH, Lazio BE, Singh SK, Chin LS.

Neurosurg Focus. 2002 Sep 15;13(3):ecp1.

PMID:
15844877
8.

Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.

Ballestrero A, Nencioni A, Boy D, Rocco I, Garuti A, Mela GS, Van Parijs L, Brossart P, Wesselborg S, Patrone F.

Clin Cancer Res. 2004 Feb 15;10(4):1463-70.

10.
11.

Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.

Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.

Int J Oncol. 2004 Dec;25(6):1849-57.

PMID:
15547726
12.

Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.

Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.

Invest Ophthalmol Vis Sci. 2005 Jan;46(1):358-66.

PMID:
15623796
13.
14.

Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.

Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH, Gores GJ.

Cancer Res. 2004 May 15;64(10):3517-24.

15.
16.

Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.

Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.

Arch Virol. 2004 Feb;149(2):289-302. Epub 2003 Nov 4.

PMID:
14745596
17.

Mechanisms of resistance to TRAIL-induced apoptosis in cancer.

Zhang L, Fang B.

Cancer Gene Ther. 2005 Mar;12(3):228-37. Review.

PMID:
15550937
18.

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.

Guan B, Yue P, Clayman GL, Sun SY.

J Cell Physiol. 2001 Jul;188(1):98-105.

PMID:
11382926
19.

Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.

Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.

Cancer Res. 2003 Jan 15;63(2):513-21.

20.

P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.

Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.

Biochem Pharmacol. 2006 Jul 28;72(3):293-307. Epub 2006 May 4.

PMID:
16753135

Supplemental Content

Support Center